A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Incyte Corporation
Incyte Corporation
J-Pharma Co., Ltd.
Centre Leon Berard
Catharina Ziekenhuis Eindhoven
Sun Yat-sen University
University of Campania Luigi Vanvitelli
GlaxoSmithKline
UNICANCER
Shanghai Zhongshan Hospital
Maimónides Biomedical Research Institute of Córdoba
UNICANCER
ITM Solucin GmbH
Zhejiang Cancer Hospital
Centre Hospitalier Universitaire Dijon
Azienda Ospedaliera Universitaria Integrata Verona
Dutch Colorectal Cancer Group
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Alliance for Clinical Trials in Oncology
Seoul National University Hospital
Fudan University
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
GERCOR - Multidisciplinary Oncology Cooperative Group
Sun Yat-sen University
University of Roma La Sapienza
Sixth Affiliated Hospital, Sun Yat-sen University
Sixth Affiliated Hospital, Sun Yat-sen University
Sun Yat-sen University
Amgen
Catharina Ziekenhuis Eindhoven
Sun Yat-sen University
Sun Yat-sen University
Medical Research Council
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Sun Yat-sen University
Federation Francophone de Cancerologie Digestive
Eli Lilly and Company
Assistance Publique - Hôpitaux de Paris
Alliance for Clinical Trials in Oncology
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Sun Yat-sen University
Sixth Affiliated Hospital, Sun Yat-sen University
Tanta University
Sun Yat-sen University
IntegraGen SA
AstraZeneca
Sun Yat-sen University
Light Sciences Oncology
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Dong-A University Hospital